Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-17-002350
Filing Date
2017-06-21
Accepted
2017-06-21 20:48:47
Documents
1
Period of Report
2017-06-19

Document Format Files

Seq Description Document Type Size
1 c88691_4.html 4  
1 c88691_4.xml 4 11909
  Complete submission text file 0000930413-17-002350.txt   14261
Mailing Address GREAT POINT PARTNERS, LLC 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address
JAY JEFFREY R (Reporting) CIK: 0001239607 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 17923861

Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Reporting) CIK: 0001281446 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 17923862

Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GREAT POINT PARTNERS LLC 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address
KROIN DAVID (Reporting) CIK: 0001397513 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 17923863